InsidersTradesSigma
한미사이언스 Stock: price and insider trades · South Korea · DART (FSS)
Track the 한미사이언스 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 한미사이언스 has logged 11 insider filings. Market capitalisation: €2,119.4bn. The latest transaction was reported on 1 July 2026 (Other). Among the most active insiders: 송영숙. All data is free.
11
Insider Decl.
0
Thresholds
€322m
3 ops.
Buy Volume
€82m
1 ops.
Sell Volume
30Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 12,111 of 25,535 companies
53.3
score / 100
Value48
Quality59
FCF yld1.2%
Earn yld5.1%
EV/EBITDA16.4x
ROE15%
Gross mgn23%
Net mgn8.7%
Debt/EBITDA1.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 1 July 2026
Declarations11 total
11 of 11 declarations
About 한미사이언스
Hanmi Science is a South Korean company focused on the healthcare and pharmaceutical sector. It is listed on the XKRX market.